251 related articles for article (PubMed ID: 28639970)
1. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wirunsawanya K; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1031-1035. PubMed ID: 28639970
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
[TBL] [Abstract][Full Text] [Related]
3. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
[TBL] [Abstract][Full Text] [Related]
5. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Sanguankeo A; Wijarnpreecha K; Upala S
Dig Liver Dis; 2017 Jun; 49(6):618-622. PubMed ID: 28274829
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Gong S; Song J; Wang L; Zhang S; Wang Y
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):132-8. PubMed ID: 26545082
[TBL] [Abstract][Full Text] [Related]
9. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
[TBL] [Abstract][Full Text] [Related]
10. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study.
Xu K; Zhao X; Fu X; Xu K; Li Z; Miao L; Li Y; Cai Z; Qiao L; Bao J
Biomed Pharmacother; 2019 Sep; 117():109158. PubMed ID: 31252266
[TBL] [Abstract][Full Text] [Related]
11. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Zhou Y; Wei F; Fan Y
Clin Biochem; 2016 May; 49(7-8):636-42. PubMed ID: 26738417
[TBL] [Abstract][Full Text] [Related]
12. Association between serum uric acid and nonalcoholic fatty liver disease in the US population.
Shih MH; Lazo M; Liu SH; Bonekamp S; Hernaez R; Clark JM
J Formos Med Assoc; 2015 Apr; 114(4):314-20. PubMed ID: 25839764
[TBL] [Abstract][Full Text] [Related]
13. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
Yu XL; Shu L; Shen XM; Zhang XY; Zheng PF
Medicine (Baltimore); 2017 Sep; 96(39):e8164. PubMed ID: 28953666
[TBL] [Abstract][Full Text] [Related]
14. Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review.
Brennan P; Clare K; George J; Dillon JF
World J Gastroenterol; 2020 Apr; 26(15):1683-1690. PubMed ID: 32351286
[TBL] [Abstract][Full Text] [Related]
15. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
[TBL] [Abstract][Full Text] [Related]
16. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study.
Wei F; Li J; Chen C; Zhang K; Cao L; Wang X; Ma J; Feng S; Li WD
Front Endocrinol (Lausanne); 2020; 11():179. PubMed ID: 32328031
[No Abstract] [Full Text] [Related]
17. The relationship of serum uric acid with non-alcoholic fatty liver disease.
Sertoglu E; Ercin CN; Celebi G; Gurel H; Kayadibi H; Genc H; Kara M; Dogru T
Clin Biochem; 2014 Apr; 47(6):383-8. PubMed ID: 24525254
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.
Jaruvongvanich V; Wirunsawanya K; Sanguankeo A; Upala S
Dig Liver Dis; 2016 Dec; 48(12):1410-1417. PubMed ID: 27697419
[TBL] [Abstract][Full Text] [Related]
19. Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.
Lin H; Li Q; Liu X; Ma H; Xia M; Wang D; Li X; Wu J; Zhao N; Pan B; Gao X
PLoS One; 2015; 10(10):e0140379. PubMed ID: 26473493
[TBL] [Abstract][Full Text] [Related]
20. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.
Yang C; Yang S; Xu W; Zhang J; Fu W; Feng C
PLoS One; 2017; 12(5):e0177249. PubMed ID: 28510581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
